Genome wide studies of mRNA synthesis and degradation in eukaryotes by Pérez-Ortín, José E. et al.
Biochimica et Biophysica Acta 1819 (2012) 604–615
Contents lists available at SciVerse ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbagrmReview
Genome-wide studies of mRNA synthesis and degradation in eukaryotes☆
José E. Pérez-Ortín a,⁎, Lola de Miguel-Jiménez b, Sebastián Chávez b
a Departamento de Bioquímica y Biología Molecular, Facultad de Biológicas, Universitat de València, C/ Dr. Moliner 50, E46100 Burjassot, Spain
b Departamento de Genética, Facultad de Biología, Universidad de Sevilla, Avda. Reina Mercedes 6, E45012 Seville, Spain☆ This article is part of a Special Issue entitled:
Processing.
⁎ Corresponding author. Tel.: +34 963543467; fax: +
E-mail addresses: jose.e.perez@uv.es (J.E. Pérez-Ortí
(L. de Miguel-Jiménez), schavez@us.es (S. Chávez).
1874-9399/$ – see front matter © 2011 Elsevier B.V. Al
doi:10.1016/j.bbagrm.2011.12.002a b s t r a c ta r t i c l e i n f oArticle history:
Received 2 October 2011
Received in revised form 1 December 2011
Accepted 5 December 2011
Available online 11 December 2011
Keywords:
Transcription rate
mRNA turnover
RNA polymerase II
Transcription elongation
mRNA stabilityIn recent years, the use of genome-wide technologies has revolutionized the study of eukaryotic transcription
producing results for thousands of genes at every step of mRNA life. The statistical analyses of the results for a
single condition, different conditions, different transcription stages, or even between different techniques, is
outlining a totally new landscape of the eukaryotic transcription process. Although most studies have been
conducted in the yeast Saccharomyces cerevisiae as a model cell, others have also focused on higher eukary-
otes, which can also be comparatively analyzed. The picture which emerges is that transcription is a more
variable process than initially suspected, with large differences between genes at each stage of the process,
from initiation to mRNA degradation, but with striking similarities for functionally related genes, indicating
that all steps are coordinately regulated. This article is part of a Special Issue entitled: Nuclear Transport
and RNA Processing.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
RNA polymerase (RNA pol) molecules are ﬁrst recruited to gene
promoters to then start transcription along the coding region of the
gene. During this process, not all molecules are able to complete
their journey, and they also undergo different modiﬁcations which
mark their particular stage during the process [1]. Eukaryotic RNA
pol II molecules are unique among transcriptases in that they have a
long C-terminal tail (CTD) with repeated (from 26 in yeast to 52 in
humans) heptads, Tyr-Ser-Pro-Thr-Ser-Pro-Ser. CTD is a target of
many reversible modiﬁcations, including phosphorylation, prolyl-
isomerization and glycosylation at various positions (see [1] for a re-
view). These modiﬁcations are catalyzed by enzymes, kinases, phos-
phatases, and prolyl-isomerases, which can thus act as “writers” of
an information code [2]. Given the large number of both repeats
and individual alternative modiﬁcation states, the theoretical number
of different RNA pol II molecules is much higher than their actual
number in a cell. Hence, it is possible that every transcribing RNA
pol differs at a given time. Although this is merely a theoretical possi-
bility, it illustrates the potential information stored and used during
the transcription process.
As stated above, the particular way a gene is transcribed can vary
somewhat from one to another. The actual differences that RNA pol II
molecules have along “a model gene” are, in part, already known [2].Nuclear Transport and RNA
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complex). Then, Ser5 phosphorylation in CTD is required to start
early elongation. Ser2 phosphorylation starts later and progressively
replaces Ser5 during elongation ([1,2] for a review). The transcrip-
tional differences between genes are, however, just emerging.
Phospho-CTD dynamics was recently described to be gene-speciﬁc
in yeast, and distinct patterns of CTD phosphorylation are present in
different classes of RNA pol II genes in yeast [2]. Moreover, it should
also be considered that differences in transcription depend not only
on RNA pol II molecules, but also on a plethora of ancillary factors
that accompany them along the gene. Elongating RNA pol II is accom-
panied by not only factors that directly affect its processivity and
elongation rate, but also by many other proteins involved in co-
transcriptional phenomena, which are as diverse as mRNA capping,
splicing, editing, cleavage, polyadenylation and export, and also as
in chromatin disassembly and reassembly (reviewed by [3]) These
factors exchange more or less freely during the transcription process.
In many instances, they are attracted by a speciﬁc type of CTD state
(see [2] for some examples) to become “readers” of the information
code. Moreover, genes differ not only in the particular amino acid
sequence they encode, but also in other sequence-dependent
features. Genes have a different length, G+C content, dinucleotide
distribution, exon/intron organization and, especially, chromatin
structure. All the cited features can inﬂuence transcription. It is likely
that they are also interdependent in terms of the particular features of
RNA pol II molecules and their partners.
Although much effort has been made to study RNA pol II recruit-
ment and transcription initiation, it now comes over quite clearly
that elongation is an important step in gene regulation. Currently, it
is tentative to speculate that most (perhaps all) eukaryotic genes
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ulation has common aspects for the groups of genes that are function-
ally related. Similarly, recent years have witnessed the discovery that,
in many instances, gene expression is post-transcriptionally regulated
by means of changes in mRNA stability. Thus the gene regulation
topic has broadened from transcription initiation to a wider ﬁeld
comprising all the stages of the process.
Many of the putative distinctive features of gene expression
between genes can only be described by comparing a statistically
relevant number of genes at the same time. This is currently possible
by using the recently developed genome-wide techniques or by
implementing new transcriptomics tools. Both strategies are much
easier when using model organisms like the yeast S. cerevisiae in
which a large set of molecular and genetics tools exists. Precisely for
this very reason, we focus on this organism; however, the implemen-
tation of some genomics techniques in other organisms (e.g., human
or Drosophila cells in culture) makes it possible to also review the
similarities and differences between those organisms.
2. How to measure transcription rates
2.1. mRNA turnover and transcription rate
Deﬁning the transcription rate (TR) is, in principle, quite simple.
The TR is the rate at which RNA molecules are produced. It is mea-
sured as molecules per minute or per hour. Nevertheless, because
there are several steps involved, from early elongation to the appear-
ance of mature RNA in the cytoplasm, it is not so easy to deﬁne the TR.
From a functional perspective, the only worthy mRNAmolecule is the
fully processed cytoplasmatic one. This is the molecule that can be
used for translation, and may be stored in cytoplasmic bodies or sub-
strates for cytoplasmic exonucleases. Although mRNAs at different
maturation stages can be found in the cytoplasm at a given time
(e.g., either containing introns or not), simpliﬁcation can be per-
formed because defective mRNAs are much less stable than correct
ones [4]; therefore, they should be a minor component at steady-
state levels. Methods to measure mRNA amount/concentration (RA)
can discriminate, or not, between intron-containing/spliced and
poly(A)/non-poly(A) molecules, which should be taken into account
when analyzing results. Nuclear pre-mRNA is also a component of
the total RNA extracted from cells, which is usually accepted as a
minor component of measurable mRNA given its fast transit to the
cytoplasm and its low stability if retained in the nucleus [5]. These
considerations can be altered if working with mutants in any of the
mRNA processing steps. In any case, we can assume that by using,
for instance, microarrays after oligo d(T)-primed cDNA labeling, the
measured RA mostly quantiﬁes cytoplasmic functional molecules.
The appearance of a processed mature mRNA in the cytoplasm can
be considered, in practice, as the actual or effective TR for the cell
(the mature TR).
It should also be noted that, in fact, the relevant parameter for
mRNA functionality is not its amount, but its concentration. Chemical
reactions are governed by the concentrations of reactants. If when
comparing mRNA amounts or concentrations cell volume is the
same, then it does not matter. However in some instances, two com-
pared samples may have a different average cell volume, which
should be taken into account.
Since mRNA is an unstable molecule by nature it has a relatively
high turnover, which is much higher in lower eukaryotes that in
higher ones [4]. Actual RA depends not only on the mature TR, but
also on the disappearance of mRNA molecules. In a nongrowing cell,
disappearance of mRNA is only due to the degradation caused by RN-
ases. We can deﬁne a degradation rate (DR) as the rate at which RNA
molecules are degraded. DR=kd RA, where kd is the degradation con-
stant. In a growing cell, as in most experiments with cultures, and es-
pecially with microorganisms (e.g., yeasts), the cells' total volumeincreases, which provokes a dilution effect on mRNA [6] and adds to
the DR. Although the dilution factor is the same for all genes, it is pro-
portionally more important for those genes with a low mRNA turn-
over [7]. On the other hand, the TR is more affected in genes with a
large RA because the TR should compensate dilution proportionally
to RA in order to keep the mRNA concentration constant. To date,
this last point has not been experimentally demonstrated. Yet it
seems logical that actively growing cells with steady-state mRNA
conditions (as demonstrated for S. cerevisiae, see [8]) would attempt
to keep mRNA concentrations constant by devoting part of their TR
to compensate dilution (see [7]). It is predicted that the measured
TR varies depending on the growth rate. The problem for such an ex-
perimental demonstration is that many genes have different RA, and
probably different TR, as a function of the growth rate [9,10].
2.2. Methods to measure RNA polymerase density: the nascent TR
In spite of the previous considerations related to the mature TR,
most genomic methods used to measure the TR have been developed
to measure the nascent TR. It can be deﬁned as the rate at which an
RNA molecule is synthesized on its template. The reason for this pref-
erence is that the nascent TR is much easier to measure. RNA pol po-
sitional information is obtained by means of a nucleic acid sequence
by either sequencing or speciﬁc probe hybridization. Some methods
detect RNA pol by means of the DNA sequences they are sited at,
while others use the nascent RNA they are transcribing. The former
does not guarantee that the RNA pol is actually transcribing and
does not offer information on the DNA strand being transcribed. The
latter may, or may not, ensure that they are being polymerized.
Some of them derive from previous single-gene methods which
have been upgraded to a genomic scale, while others have been
directly developed for genomics studies.
Historically speaking, the ﬁrst method to detect RNA pol on specif-
ic sequences was the transcription run-on (TRO) method [11]. Since
2002, several genomic upgrades of TRO have appeared for different
organisms. The most comprehensive studies were published by the
groups of Myriam Gorospe [12,13] and Jack D. Keene [14] in mamma-
lian cells, and by Legen et al. in plants [15]. In 2004 [16], a genomic
upgrade for the yeast S. cerevisiae called “genomic run-on” (GRO)
was developed. All these protocols use total RNA isolation and its sub-
sequent hybridization onto nylon macroarrays. In 2008, Core et al.,
[17] developed a GRO-seq protocol for human cells by adapting it
for high-throughput sequencing (HTS) technologies. Fig. 1B depicts
the outline of the GRO method. The signal corresponding to a given
sequence (the probe in the DNA array, the number of hits in HTS) is
an indication of the average RNA pol density in it. If we consider a
constant speed (elongation rate, see Section 3.1) for the RNA pol,
RNA pol density is directly proportional to its transcription rate. Use
of PCR-ampliﬁed probes provides an average for elongating RNA pol
(green ovals in Fig. 1) density in the probe region (usually the
whole ORF) in both the sense+antisense orientations. Use of single
oligonucleotide probes or HTS provides a local RNA pol density in
only one orientation. Therefore, when using tiling arrays or GRO-seq
experiments, a precise map of RNA pol distribution throughout the
genome is obtained [18; Jordán-Pla et al., in preparation]. Employing
GRO in yeast is very easy and can be used in many situations, even
during rapid changes because it needs a relatively low number of
cells (109) and does not need to isolate nuclei. This allows the physi-
ological state of cells to be frozen at the time of sarkosyl addition.
Other techniques do not allow this simplicity and quickness.
Another commonly used technique is the immunoprecipitation of
RNA pol II cross-linked to its bound DNA by means of speciﬁc anti-
bodies (Fig. 1C), which is a mere variation of the general chromatin
immunoprecipitation method (ChIP) adapted for RNA pol II. Genera-
tion of RNA pol II density precisely maps where RNA pol is seated. The
method can be used in combination with all kinds of arrays (ChIP-
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on the protocol type in the same way described for GRO. This meth-
odology is also quite simple and fast, so it can be also used in rapid
physiological changes for all kinds of cell cultures [22]. A critical fea-
ture is that RNA pol II molecules can be distinguished from other
RNA polymerases, and even their phosphorylation state can be dis-
criminated using speciﬁc antibodies [19,2]. Other genome-wide
methods employed to study transcription elongation by means of na-
scent mRNA isolation (Fig. 1) have not yet been implemented to ob-
tain nascent TR data, although they are susceptible to that.
A common feature for all nascent TR methods is that they should
be converted into absolute units by comparing their datasets with
the indirect TR ones. Thus, the obtained values correspond to “pro-
ductive” transcription (see Section 2.5). That is to say, the real nascent
TR is not known. Only the transcription events which become a ma-
ture mRNA in the cytoplasm are counted. The real nascent TR should
be higher because many unproductive events exist. The comparison
made between individual genes is still possible because a common
factor is used to multiply them all [7].
Therefore, the combination of genome-wide results obtained by
different methodologies and with conventional mRNA quantiﬁcation
techniques, either high- or low-resolution, is a potential tool to dis-
criminate the transcriptional features of different genes.2.3. A snapshot of eukaryotic transcription
The GRO protocol enables the ﬁrst whole TR dataset to be obtained
for an organism [7]. Thus, 90% of yeast genes show TRs per cell of be-
tween 2 and 30 mRNAs/h, with a median per cell of 7 mRNAs/h. This
corresponds to 0.078 RNA pol II molecules/kb and 0.1 molecules/
gene. Given the much skewed distribution toward highly transcribed
genes, RNA pol II molecules are scarce in yeast genes: only 14% of
genes have any actively transcribing RNA pol II molecule. Hence, tran-
scription onto canonical genes does not seem to be a common feature
of the yeast genome. In spite of the 20,000 RNA pol II molecules/cell
[23] only around 700–1400, according to our calculations, are actually
transcribing those genes encoding proteins at a given time. One pos-
sibility is that part of these molecules is unable to productively tran-
scribe. However, the amount of CTD-phosphorylated molecules
(12,000, according to ref. [23]) suggests that they can transcribe in
other regions outside canonical genes (see the next section), or per-
haps that the mRNAmolecules which reach the cytoplasm are merely
a fraction of the nascent ones, as previously explained. The most tran-
scribed genes are those that encode histones, with an average TR of
~200 mRNAs/h in the S phase, whereas ribosomal protein (RP)
genes are less transcribed than previously thought (see refs. [7,24]
for a discussion). The analysis done by P. Cramer's group using a dif-
ferent method (see Section 2.5) obtained similar results: a skewed
distribution of transcripts, from 0.7 to 400 mRNAs/h, and a low global
transcription rate with a medianmRNA synthesis of 12 mRNAs/h [20].
A similar study was recently performed in mouse ﬁbroblasts by
[25]. It shows that the median TR in those cells is 2 mRNAs/h, with
a distribution of between 0.2 and 20 mRNAs/h for most genes.
Given that ﬁbroblasts are 20–50 times larger than a yeast cell, TRs
are relatively much lower than in yeast if we expect them to support
the higher synthesis required to achieve similar mRNA concentra-
tions. However, the mRNA steady-state concentrations seem to be
lower because the actual mRNA amounts in ﬁbroblasts (average ~30
mRNAs/cell) are only 10 times higher than in yeast (average ~3
mRNAs/cell, in [7]). This partially accounts for their lower TR. On
the other hand, the mRNAs of higher eukaryotes are more stable (me-
dian half-life ~40 min in [26], but higher values in other references
[25]) than in yeast (median half-life of 23 min [27]), which explains
the remaining difference in the TR. Thus, it seems that the TRs of
higher eukaryotes are even lower than in yeast because they havemore stable mRNAs and lower mRNA concentrations. In this case,
the snapshot reveals an even scarcer RNA pol II outlook.
The conclusion drawn from these studies is that the productive
transcription of canonical mRNAs in a eukaryotic cell is quite low, al-
though real total transcription may be higher (see the next section).
Given the translation rate for both yeasts (~6 proteins per mRNA
per hour, [28]) and mouse ﬁbroblasts (40 proteins per mRNA per
hour, [25]), and the much higher number of mRNAs/cell (in the
range of 104 in yeast and of 105 in ﬁbroblasts) if compared with
1–2 gene copies/cell, the cost in translation is much higher than in
transcription for a eukaryotic cell, as previously anticipated using
nongenomic data [29].
2.4. Inﬂuence of cryptic transcription in nascent TR determinations and
gene regulation
A potential artifact of nascent TRmethods is interference of cryptic
transcription. Cryptic transcripts are deﬁned as those which are difﬁ-
cult to detect given their small amount and because they lack corre-
spondence with predicted canonical genes. Since functional
genomics techniques came about, a plethora of different kinds of
cryptic transcripts was detected in all the eukaryotes studied. There
is much controversy as to the magnitude and signiﬁcance of cryptic
transcription [30,32]. In any case, there is no doubt that RNA pol II
transcribes more RNAs than previously assumed.
The RNA pol II molecules placed anywhere along the genome re-
gions contained in microarray probes can be detected irrespectively
of them transcribing “canonical” transcripts or cryptic transcripts.
Cryptic transcripts account for both the sense and antisense tran-
scripts overlapping canonical transcripts. Some nascent TR methods
are intrinsically nondiscriminating for sense or antisense transcripts:
ChIP, because of the double-strand nature of the immunoprecipitated
DNA; the original GROmethod, given the dsDNA nature of the macro-
chip probes used [33]. For these reasons, both sense (canonical and
cryptic) and antisense transcriptions are summed in the signal. A
huge number of cryptic transcripts was demonstrated in many organ-
isms, including yeast (see [31]). In yeast, two main types were de-
ﬁned: cryptic unstable transcripts (CUT), which are only detectable
in the absence of nuclear exosome activity and stable uncharacterized
transcripts (SUT) [34]. Another class of cryptic unstable transcripts
was recently described (XUT, Xrn1-sensitive unstable transcripts)
and it was proposed to be degraded by the Xrn1 5′-exonuclease in
the cytoplasm. Therefore, they increase in an xrn1 mutant [35].
Some authors argue that cryptic transcription can be responsible for
the differences observed in some genes' response to stress situations
when comparing mRNA data and RNA pol II ChIP data [18,34,35]. This
contrasts with recent evidence for a small amount of antisense tran-
scripts compared to the canonic mRNA pool in the bidirectional pro-
moters context [31,37].
We analyzed several of the different cryptic transcription datasets
published [34–36,38] in relation to the uncoupling between the TR
and RA proﬁles. We found that there is no statistical correlation be-
tween the presence of a cryptic transcript in a gene and the lack of
the correspondence of the RA proﬁles and TR proﬁles during a stress
response (García-Martínez et al., submitted). Therefore, we conclude
that the main reason why RA proﬁles differ from the TR ones lies in
the changes occurring in the DR (mRNA stability), as explained
below. We believe that the nascent TR reﬂects mainly the “canonical
transcription” for most genes. In fact, as there is very little overlap-
ping between the different datasets, it seems that most yeast genes
have cryptic transcripts. However, the majority of them are in a
very low proportion to their canonical counterpart (discussed in
[31]); thus, the mere presence of an overlapping cryptic transcript is
not a way to classify genes. Nonetheless, we observed some statisti-
cally signiﬁcant biases in those genes whose expression increases
during the stress response, as well as some kinds of cryptic transcripts
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Then it is converted into cDNA and used for tiling array hybridization [55]. B) Alternatively, cells can be used for the GRO analysis. During run-on, cells are permeabilized with sarkosyl,
which abruptly decreases NTP pools and stops all elongating RNA pol. The detergent also disrupts the chromatin structure, thus avoiding a further initiation event. A subsequent pulse of
externally added ribonucleotides, including labeled UTP (33P-UTP, thio-UTP or biotin-UTP), induces a short elongation (about 200–300 nucleotides for 33P-UTP) of these RNA pol (green
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nary complex, either DNA or RNA can be isolated frompolymerases and analyzed. Recovered DNA is suitable for array hybridization (ChIP-chip) [8,19,69] orHTS (ChIP-Seq),whereas RNA
can be converted into cDNA and subjected to HTS [37]. D) Appearance of recently synthesizedmRNA (newborn, orange) in the cytoplasm can be followed by thio-uridine in vivo labeling
(yellow “S” onto nascent RNA), which is puriﬁed, quantiﬁed and comparedwith the nonlabeled oldmRNA (green).With this technique, it is possible to calculate themature TR andmRNA
half-lives at the same time (DTA; [20]). E) mRNA half-lives can also be calculated from a transcription shutoff experiment [27], or F) from TR and RA data by assuming the steady state
(kd=TR/RA). In this last case, the mature TR can be alternatively calculated from RA and kd data.
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translation-related genes), which are enriched in other kinds of cryp-
tic transcripts [García-Martínez et al., submitted]. These results arguethat although cryptic transcription is not a main factor to alter the TR
evaluation during stress responses, it proves to be a contributor to the
regulation of some speciﬁc gene groups [35,36]. Along these lines,
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antisense transcription in both S. cerevisiae [39] and S. pombe [38].
2.5. Methods for evaluating the mature transcription rate
Cell control on mRNA concentration should be implemented in
relation to the valuable molecules that are useful for translation;
that is, the cytoplasmatic ones. The rate at which newborn mRNA ap-
pear in the cytoplasm can be termed the mature TR (Fig. 1D). Current
methods for determining the mature TR are based on the in vivomet-
abolic labeling of transcripts with uracil or uridine analog pulses. If
the pulse is short enough and the mature TR is considered constant
during this pulse, the subsequent isolation of labeled (newborn)
mRNA is a method to evaluate the mature TR [40]. Quantiﬁcation of
non-labeled (old) or total mRNA allows measuring RA in the same
experiment. The recently developed dynamic transcriptome analysis
(DTA) methodology in yeast [20] and mammalian cells [25,26] is
based on the puriﬁcation of newborn mature transcripts after a met-
abolic pulse of 4-thiouridine with varying times (6 min in yeast, and
from 10 min to 2 h in mammals). Given the simultaneous calculation
of RA, it can also determine mRNA half-lives at the same time, thus
assuming a steady-state situation (see Section 4.1).
On the other hand, the mature TR can also be calculated from RA
and mRNA stability datasets indirectly (indirect TR, TRi=kd RA) by
assuming a steady state [41]. Alternatively, mRNA half-lives (or kd)
can be calculated indirectly from experimental mature TR and RA
datasets using the same equation (see Section 4.1). Both indirect
calculations involve the problem of a higher error being caused by
the mathematical process (see [7,42] for a discussion).
2.6. Differences between the nascent and mature transcription rates
Genes may be clustered according to their proﬁles when studying
the expression of the whole gene set of a eukaryote using genomic
techniques. Clustering may reﬂect the existence of a common regula-
tion of these genes. This is usually assumed to be controlled by a tran-
scription factor (TF), and it is named a regulon [6]. Most studies use
RA determinations to compare the expression of genes. However,
one change in RA can be the outcome of not only a change in the
TR, but also in mRNA stability, or even in both. The most common
direct effect of a TF is noted on the nascent TR. Therefore, according
to the nascent TR, clustering should be the best method to detect reg-
ulons. Even the rate at which mRNA appears in the cytoplasm (the
mature TR) may be less suitable for regulon detection because some
post-transcriptional events, like mRNA export, can affect the mature
TR proﬁle. In fact, an independent meta-analysis of previously pub-
lished data [16,43,44] reveals that TR proﬁles are more suitable to
predict functional relatedness than RA proﬁles [45]. Although only
formally demonstrated in S. cerevisiae, it seems reasonable to extend
this conclusion to other eukaryotes.
The nascent TR also seems the best way to classify genes according
to active chromatin marks. The passage of RNA pol II molecules along
the chromatin template is affected by a particular nucleosomal orga-
nization (see Section 3.4). Since the nascent TR measures the actual
elongation rate, which is affected by nucleosome structure and posi-
tioning, it should better correlate with the characteristic chromatin
marks of active genes than the mature TR. Comparing the level of
the different active chromatin features, such as H3-K36 trimethylation
or enrichment in Esa1p or Gcn5p histone acetyltransferases, revealed
that the correlation with the nascent TR (calculated by GRO) is great-
er than when compared with the RA or with the indirect mature TR
[7].
The mature TR, however, is best suited for kinetic studies because
it is directly related with the cytoplasmic mRNA steady-state and is
not affected by cryptic transcription, as previously mentioned. So it
is that each kind of TR dataset is appropriate for a given goal. A recentreview [46] provided a compendium of features and advantages of
each TR determination method. Comparing all existing yeast TR data-
sets with each other and with a standardized RA dataset revealed that
they all correlate quite well [24]. Those corresponding to the nascent
TR correlate better with each other, and the same may be said for
those corresponding to the mature TR, which also has better corre-
lates with the RA dataset. These results are logical because nascent
mRNAs should be processed and exported to the cytoplasm where
the mature TR is measured. Thanks to the comparative analyses of
both nascent andmature TRs, datasets should provide further insights
into differences in the post-transcriptional steps between the differ-
ent groups of genes.
3. Functional insights into transcription elongation obtained from
genome-wide studies
3.1. How to study elongation
How to approach transcription elongation quantitatively is an
open problem with different partial solutions. Studying transcription
elongation in vivo has involved the use of very diverse techniques, in-
cluding depletion of intracellular pools of ribonucleotide triphos-
phates by drugs like 6-azauracile [47] and mycophenolic acid [48],
or the comparison of reporter genes of varying lengths [49,50]. By
using antibodies against RNA pol II (Fig. 1C), chromatin immunopre-
cipitation enables the measurement of elongation rates and proces-
sivity [51]. The elongation rate is the speed at which RNA pol runs
along its template. It is measured in kb per minute or per second.
The same genomic techniques followed to study transcription elonga-
tion can be used to measure the nascent TR (Section 2.2 and Fig. 1),
although the output data differ. Some of their drawbacks are also sim-
ilar: the ChIP of RNA pol II lacks speciﬁcity against the active,
elongation-competent form of RNA polymerases as they are detected
regardless of the transcriptional states (active, paused, backtracked;
see Fig. 1). In vitro studies showed that RNA pol II is often arrested
(red ovals in Fig. 1) during elongation in the chromatin context
[52], while molecular modeling indicated that backtracking during
elongation is indeed a frequent phenomenon in vivo [53]. Therefore,
the presence of polymerase in a region should not be directly as-
sumed to be an actual transcription. Moreover, ChIP also detects the
RNA pol II molecules sited at the promoter before elongation (yellow
ovals in Fig. 1). On top of this, ChIP cannot discriminate the sense/
antisense transcripts, even when using strand-speciﬁc probes or HTS.
In addition to run-on (see Section 2.2), other techniques can par-
tially skirt this drawback (Fig. 1). Native elongating transcript se-
quencing (NET-seq) is a HTS-based technique which provides
information on the position of elongating RNA pol II within highly
expressed genes on a genome-wide scale, thus avoiding the problems
mentioned. It involves the isolation and HTS of the nascent transcript
associated with immunoprecipitated RNA pol II [37,54]. Nascent
mRNAs were also directly puriﬁed from isolated chromatin converted
into cDNA and hybridized to tiling arrays (Fig. 1A) [55]. In both these
cases, only the RNA pol with a bound transcript is located. This result
comes closer to that of GRO, but is not identical because non-
elongating or backtracked RNA pol II molecules are detected. Thus,
the existence of several alternative methods to map RNA pol allows
research into transcription elongation by distinguishing all the RNA
pol II states in its template (see Fig. 1).
3.2. Genomic ChIP approaches to elongation
By utilizing antibodies that speciﬁcally recognize RNA pol II, ChIP-
chip and ChIP-seq analyses demonstrated that transcriptional regula-
tion at the post-initiation stages is a common phenomenon across
metazoan genomes. At least 40% of the genes present a promoter-
proximal accumulation of RNA polymerase II (Fig. 2A) in mammalian,
A)
B)
Fig. 2. Transcription elongation features revealed by genomic studies. Genomic high resolution mapping of RNA pol II across the genome, either by ChIP or run-on, has revealed that
promoter proximal pausing is a common phenomenon in metazoa (A), but not in the yeast S. cerevisiae (B). Statistical accumulation of RNA polymerase II shortly downstream of the
transcription start site may result from either a longer resident time or premature termination. The comparison made between RNA pol II distribution and nucleosome positioning
maps indicates that promoter-proximal pausing takes place at nucleosome +1 (A). In yeast, nucleosome +1 frequently covers the transcription start site, while the NET-seq data
suggest that RNA pol II pauses at any positioned nucleosome throughout the transcribe region (B). Evidence from certain metazoan individual genes and from yeast NET-seq
indicates that paused RNA pol II becomes easily backtracked (red ovals) and that TFIIS acts during backtracked RNA pol II reactivation.
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pol II chip and histones ChIP approaches revealed that a subgroup of
the so-called bivalent genes, bound by Polycomb repressive complex
2, displays stalled RNA pol II. The bivalent genes in embryonic stem
cells display characteristic chromatin markers of silenced (histone
H3K27 tri-methylation) and active transcription (histone H3K4
tri-methylation) [60]. Other mammalian examples of promoter-
proximal accumulation of RNA pol II are growth-promoting, pro-
oncogenic genes like FOS and MYC, which preferentially reside in
compact chromatin, and are inefﬁciently transcribed under basal con-
ditions [61].
In yeast (Fig. 2B), ChIP-chip analyses revealed that almost 2500 re-
pressed genes show poised RNA pol II in the stationary phase [62], butthat only a few, like CYC1 and those encoding NTP-biosynthetic en-
zymes, display an accumulation of RNA pol II in their 5′ region
under repressive conditions in exponentially growing cells [63,64].
For NTP genes, transcription regulation works at the initiation level
through an attenuation mechanism [64,65]. It is not clear whether
the accumulation of RNA pol II at the 5′ end in the other cases re-
sponds to a pausing phenomenon. In any case, RNA pol II pausing at
the promoter-proximal sites is not a frequent phenomenon in expo-
nentially growing yeast [66]. ChIP has been also used at the genomic
level to distinguish the different forms of CTD phosphorylation [19,2].
Ser5 phosphorylation shows a characteristic peak at the beginning
of the transcribed region [19,2] whereas Ser2 and Ser7 present
more uniform patterns [19,2]. Moreover, a constant delay of Ser2
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length, was found [2].
3.3. GRO and nascent RNA isolation as approaches to elongation
GRO is also a useful tool to study elongation. The relative distribu-
tion of the run-on signals across the genome also proved most useful
to detect promoter proximal pausing (Fig. 2A), as well as other im-
portant features of eukaryotic gene expression, such as divergent
transcription [17,67]. Our group used GRO proﬁles, quantiﬁed as 3′/
5′ ratios, to detect the gene-speciﬁc transcription elongation patterns
and the functional roles of general transcription factors in elongation
[68].
A comparison of the genomic patterns of run-on signals, reﬂecting
elongation-proﬁcient RNA polymerases, with the genomic distribu-
tion of the total RNA pol II (Fig. 2B) measured by ChIP is an efﬁcient
way of detecting RNA pol II arrest during elongation [69]. The correla-
tion between run-on and ChIP signals is a generally good, but some
gene ontology categories exhibit lower run-on values than expected
depending on their ChIP signals [69]. This difference is particularly
striking for those genes encoding ribosomal proteins (RP), indicating
the accumulation of arrested RNA pol II in these genes. One particular
behavior of RNA pol II during transcription elongation of RP genes is
also reﬂected by the 5′-biased distribution of the run-on signals in
this speciﬁc group of genes [68].
The run-on signals of RP genes lowered when comparing the yeast
cells exponentially growing in a glucose-containing medium to
those cells exponentially growing in galactose-containing medium.
However, this drop was signiﬁcantly more marked in the total RNA
pol II levels detected by ChIP than in the run-on signals; accordingly,
the run-on/ChIP ratio for the RP genes diminished from glucose to
galactose. The simplest interpretation of these results is a speciﬁc re-
duction in the number of backtracked RNA pol II complexes in re-
sponse to the carbon source. In fact, the run-on/ChIP ratio depends
on the integrity of the Ras–PKA pathway and is mediated by the si-
lencing domain of Rap1, an essential transcription factor for RP
genes transcription [69]. In short, comparison of genomic RNA poly-
merase II ChIP and GRO indicates that RNA pol II arrests are an impor-
tant ingredient of transcriptional regulation.
Native elongating transcript sequencing (NET-seq) is a comple-
mentary genomic tool to study elongation [37]. It provides transcrip-
tional proﬁles at a nucleotide resolution and allows the detection of
pervasive RNA pol II pausing through the body of highly transcribed
genes, with prominent peaks at all the ﬁrst four positioned nucleo-
somes (Fig. 2B) [37]. The NET-seq patterns in a mutant lacking the
RNA-cleavage factor TFIIS display a large-scale downstream shift of
5–18 bp at the position of the paused RNA polymerases, suggesting
that most of the pausing in the wild type results in arrest and back-
tracking, and that a slow step follows cleavage before transcription
resumes [37]. TFIIS also plays a key role in the regulation of transcrip-
tion elongation. Involvement of TFIIS in the activation of stalled RNA
pol II was ﬁrst demonstrated for those occupying the promoter prox-
imal region of Drosophila Hsp70 [70]. In vivo TFIIS depletion using
RNA interference provoked a delay in Hsp70 induction in response
to heat shock which, in this case, was only possible after a new
round of transcription initiation [70]. A combination of RNA polymer-
ase and TFIIS ChIPs evidenced a transcription repression mechanism
based on the inhibition of TFIIS recruitment during early elongation
in pro-oncogenic genes like FOS andMYC [61]. A series of experiments
carried out in our lab suggested that TFIIS is also speciﬁcally involved
in the regulation of RNA pol II elongation on RP genes in yeast, at least
under the strong transcriptional stress caused by 6 AU [Gómez-
Herreros et al., submitted].
The importance of RNA pol II arrest, TFIIS and other arrest-
counteracting factors, like Ccr4-Not [71], in regulating transcription
elongation is likely related to the interplay between elongating RNApol II and positioned nucleosomes. In vitro experiments demonstrated
that TFIIS promotes pol II transcription through the nucleosome [52],
and that TFIIS modiﬁes the mechanical performance of RNA pol II,
allowing it to operate against higher loads, like those expected in
the positioned nucleosomes context [72]. Studies of this interplay
between RNA pol II elongation and chromatin structures are still
scarce. A clear correlation was found in higher eukaryotes between
promoter-proximal pausing and the chromatin conﬁguration of the
5′ regions [72]. Unlike S. cerevisiae, Drosophila does not bury its tran-
scriptional start site in the +1 nucleosome (Fig. 2A). At thousands of
Drosophila genes, RNA pol II initiates in a nucleosome-free region,
engages +1 nucleosome, and pauses [73].
Additionally to the previous results, a NET-seq study in yeast [37]
restricted the importance of cryptic transcription (see Section 2.4)
and determined the role of the Rpd3S histone deacetylase complex
in it. Moreover, it revealed that the elongation process is far from
being uniform: it is punctuated by pauses related with nucleosomes
(see above), which can spend times that are comparable to those
that the RNA pol II employs to move forward. Another reason for non-
uniform elongation stems from the work of Carrillo-Osterreich et al.
[55] by means of nascent RNA isolation after chromatin puriﬁcation
in yeast (Fig. 1A). These authors found that RNA pol II molecules
pause within the terminal exons in those genes containing introns
to allow co-transcriptional splicing.
These results are a good example of how transcription elongation
dynamics is more complicated than initially suspected and of how it
results from the interplay among the elongating RNA polymerases,
chromatin and factors associated with the elongation complex. Inter-
preting the biological meaning of the genome-wide comparison
between elongating RNA proﬁles with chromatin, elongation factors
and other associated factors binding maps [74] is an exciting chal-
lenge for the near future.
4. The importance of mRNA stability
4.1. Genomic-wide methods to evaluate mRNA stabilities.
At any time, RA is the result of the balance between the TR and the
DR (Fig. 1F). When RA needs to be changed, it is possible to vary the
TR, the DR, or both. Traditionally, most studies into gene expression at
either the single gene level or the functional genomics level have un-
conditionally assumed that changes in RA are due to changes in the
TR. In other words, a given gene is expressed because a TF binds its
promoter and attracts RNA pol II to transcribe it (increasing the TR)
which, in turn, increases RA. Thus, RA proﬁles were implicitly consid-
ered the direct result of TR proﬁles. However, the same effect on RA
can be obtained by an inverse change in the DR rather than in the
TR. mRNA half-lives were found to vastly differ among mRNAs, phys-
iological conditions and organisms [4]. Thanks to the development of
genomics methods [27], it is now clear that the mRNAs encoding
those proteins belonging to the same pathways or functions tend to
have similar half-lives. This suggests that regulons also exist for the
control of mRNA DRs [75]. Two types of trans factors which control
these post-transcriptional regulons have been described to date:
RNA-binding proteins (RBP) [83] and micro RNAs (miRNA) [76].
Genomic-wide mRNA stabilities can be determined directly by
using transcription shut-off methods (Fig. 1E) [27,77]. These methods
pose some problems as to the potential artifacts they cause in cells
(discussed in [42]). In some cases, the DR is not directly measured,
but RA and the TR are. Moreover, mRNA stability can be estimated
from them (Fig. 1F). We used the GRO method to determine mRNA
stabilities from TR and RA data by assuming steady-state conditions
[16] or by using a mathematical approximation when assuming that
they are not [42–44,78]. Other authors used mature TR evaluation
methods (see above) in both yeast [20] and higher eukaryotic cells
[26], which are able to determine the DR at the same time.
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Although post-transcriptional regulons were proposed on the
basis of the differences in the mRNA stability found when comparing
different genes situations, and also based on the existence of RBPs
[27,75], the fact that functionally-related groups of genes follow com-
mon DR proﬁles during transcriptional responses was ﬁrst demon-
strated by a GRO analysis of the yeast response to a carbon source
change [16]. As the GRO technique is able to indirectly determine
mRNA stabilities in steady-state situations, it revealed that the
genes belonging to functionally-related groups behave coordinately
with the DR. Similar studies in other organisms obtained comparable
conclusions, although not at the whole genome-scale level (e.g.,
[12,14]). In the carbon source change experiment, the times selected
were separated by hours, and the steady-state conditions can apply to
each one [16]. However, fast responses, typical of stress situations, do
not meet the steady-state conditions. For these cases, a mathematical
algorithm based on the use of chemical kinetic laws was developed
[42], which made it possible to determine approximate kd proﬁles
in response to different stresses for most genes and to quantify the
inﬂuence of DR changes on RA proﬁles. Our studies [43,44,78], and
those of others [79,80], revealed that changes in the DR take place
during stress responses for many genes which respond positively
or negatively to stress. The mRNA stability of many other genes, how-
ever, does not change substantially. In line with this, interesting dif-
ferences were noted between various stresses [79], which probably
depend on stress intensity. It is interesting to note that some genes,
which do not exhibit a coordinated behavior at the TR level, and
are, therefore, not part of a regulon, actually display coordinated
behavior at the mRNA stability level. This is the case of mitochondrial
RP genes, which cluster in the mRNA stability analysis, but not in the
TR analysis, during the shift from a glucose to a galactose medium
[16]. These genes do not show obvious common regulatory elements
in their promoters, but a Puf3-binding sequence in their 3′-UTR,
which was veriﬁed to coordinate their stability during changes in re-
spiratory behavior [81].
Both the TR and DR can cooperate in the transcriptional response.
There are many cases in which genes increase RA by rising their TR
and lowering their DR (increase in mRNA stability) for several mi-
nutes; for instance, after osmotic stress in S. cerevisiae [44]. A similar
result in the same stress response was reported by other authors
using a different method to measure mRNA stabilities [80], and by
Shalem et al. [79] during the yeast oxidative stress response. After
some minutes of stress, these genes reverse the change in the DR in
parallel to the transcription shut-off. This effect was interpreted as a
DR change which precedes changes in RA [80]. In other instances,
the DR acts as an intuitively opposite counter to the TR. mRNA stabil-
ity decreases while the TR increases. This strategy is energy-
consuming because of the futile cycle involved, but it speeds up the
response because the kinetics of the transcriptional change is inverse-
ly proportional to mRNA stability [42]. Several authors working in
yeast [79] or mammalian cells [26] postulated that these kinds of
changes in the DR thus contribute to sharpen response peaks. It is in-
teresting to note that many of the short-lived mRNAs in mammalian
cells are targets of miRNAs [26], which is indicative of the important
role of those regulatory trans factors in mRNA stability and, therefore,
in gene expression responses in higher eukaryotes.
4.3. The respective roles of both the TR and DR in gene expression
Altogether this published evidence indicates the importance of the
DR in controlling mRNA levels during gene regulation. However, de-
spite both the TR and DR being theoretically equivalents, they do
not play the same role in determining the amount of mRNA in stress
responses or under steady-state conditions. When comparing the TR,
the RA and the mRNA half-life datasets, it appears that the TR and RAalways present a positive signiﬁcant correlation, whereas the mRNA
half-lives do not correlate with RA and/or the TR. Moreover, mRNA
half-lives reveal slightly negative correlations with RA and the TR in
yeast [16,20] or mammalian [25] cells. On the other hand, when
measuring the number of genes with response proﬁles that are signif-
icantly affected by DR changes, the vast majority of genes show
that TR changes are the main determinant of RA proﬁles
[16,25,26,43,77]. Thus, it seems that the DR is not utilized by the
cell to control most of the mRNA levels in the majority of situations,
but to distinguish between rapid or less-rapid responsive genes
according to the half-lives of their mRNA [26,42]. Many mRNAs
have a relatively constant DR and are, perhaps, not part of a post-
transcriptional regulon. Other gene categories (stress-induced and
RP yeast genes in responses to stress [43,44], yeast mitochondria-
related genes when carbon source shifts from glucose to galactose
[16] or inﬂammatory and immune signaling genes in dendritic cells
[26]) show a highly dynamic DR. This is probably due to the cis ele-
ments present in their 3′-UTRs, which make them targets of special-
ized RBPs [78,82,83]. A general change in DR is also observed under
nongrowth conditions, like the stationary phase [84] or after a change
from glucose to galactose medium in yeast [16,85]. This phenomenon
probably results from a general change in the DRmachinery and/or p-
body organization.
The corollary of these results is that each particular group of genes
has a coordinated TR through their common promoter and chromatin
organization, and a coordinated DR through their common 3′-UTR se-
quences, which are subjected to (transcriptional) regulons and post-
transcriptional regulons [82]. It would be interesting to check if the
same genes belong to the regulons and post-transcriptional regulons,
or whether some combination exists.
5. How the transcription rate and mRNA stability can be
coordinated
5.1. Crosstalk between the transcription and degradation rates
Maintaining proper mRNA levels is critical for the proper function-
ality of any living cell. These levels are controlled by the balance be-
tween the synthesis and degradation rates. It is quite likely that all
the processes with more than one controlling point must have mech-
anisms to coordinate them. Failure to coordinate these processes
might result in an improper level. Nevertheless, it is known that in
different circumstances, the total mRNA level varies; however, this
variation is never excessive. For instance, in yeast, we found that
the total poly(A) level varies between strains or physiological situa-
tions within a less than three-fold range (Pérez-Ortín et al., unpub-
lished observations). There seems to be a homeostatic control of the
total mRNA level in the cell, which is, obviously, independent of the
knownwide variations in many individual mRNAs levels that respond
to environmental circumstances. In this sense, and as stated above,
the particular level of each mRNA is controlled by acting at both the
transcription and degradation rates. Moreover, functionally related
groups of genes are coordinated by using both regulons and post-
transcriptional regulons. Following the previous reasoning, coordina-
tion between both kinds of regulons should exist.
How does the cell sense the mRNA level and how does it coordi-
nate general and particular TRs and DRs? M. Choder's group
demonstrated that a class of proteins, which they call “mRNA coor-
dinators”, is loaded onto mRNA during its transcription, remains
bound to mRNA and accompanies it through the different stages
of its life. An mRNA coordinator can, thus, regulate mRNA export,
translation, its assembly with a p-body and its stability [86–88].
These authors proposed that the Rpb4/7 heterodimer, which was
originally viewed merely as subunits of RNA pol II to function as a
subunit of the translation and decay apparatus, acts as a prototype
of mRNA coordinators. In yeast, deletion of rpb4 alters not only
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[89], mRNA half-lives [86,90], p-body association, and even transla-
tion [88]. Thus, this mRNA coordinator acts as a general guard of
many mRNAs and can, therefore, transmit information from the
transcription process to later stages of mRNA life. Conversely,
some components of cytoplasmic mRNA degradation machines,
such as Xrn1, the Dcp1/2 Pat1/Lsm1-7 complex, among others, can
travel to the nucleus and act as transcription factors. In xrn1 mu-
tants, the TR of every gene lowers in such a way that it seems to
correlate with the effect of the mutations on mRNA stability. In
this mutant, most mRNAs' levels do not change much despite
their abnormally high stability [Haimovich et al. submitted]. So, it
seems that Xrn1 and other decay factors also deliver information,
in this case, from the cytoplasm (DR) to the nucleus (TR). Other re-
cent examples of shuttling mRNA binding factors include the Ssd1
protein [91] and the Ccr4–Not complex. Ccr4/Pop2 is the major cy-
toplasmic mRNA deadenylase, whereas Not proteins are compo-
nents of the mRNA processing bodies. Ccr4–Not was established to
act as a positive elongation factor for RNA pol II, probably by pro-
moting the resumption of the elongation of arrested RNA pol II
[71]. Consistently with their dual role in two separate compart-
ments, these proteins shuttle back and forth between the nucleus
and the cytoplasm. Rpb4/7 subunits also travel back to the nucleus
after mRNA decay [92], whereas decay factors travel back to the
cytoplasm after activating the TR. Therefore, the gene expression
process seems to be a circular system [Haimovich et al. submitted].
Although not formally demonstrated, the functional similarities
between Rpb4/7 and some other RNA-binding proteins in other
eukaryotes mean that it is quite likely that similar mechanisms
exist in organisms other than yeast [93].
In light of this, recent studies compared transcription and mRNA
decay in two related yeasts, S. cerevisiae and S. paradoxus, to ﬁnd
that the evolution of transcription and mRNA decay processes is co-
ordinated because the genes that diverge in mRNA degradation
tend to also diverge in transcription [94]. An analysis of a hybrid
of these two species showed that changes in transcription and
mRNA degradation are likely driven by the same individual muta-
tions. The factors involved in both processes (e.g., Rpb4/7 and
Ccr4–Not) seem to be associated with the observed changes. Thus,A)
Fig. 3.Models for the trans factor recognition of their mRNA targets. A) A transcribing RNA po
its CTD, yellow line), which may jump to nascent mRNA (red wave line) or to a target seque
Secondary factors (brown ovals) can use primary ones to indirectly bind nascent mRNA. The
stability, translation or p-body association. In the cytoplasm, other factors (yellow ovals)may
irrespectively of a target sequence, they can only dissociate from mRNA. The factors that rec
sociation equilibrium. All kinds of factors can be imported into the nucleus when released fro
mRNA amount. B) The table shows putative or demonstrated examples of every kind of facta single mutation in this kind of factors can result in a simultaneous
effect on both mRNA synthesis and decay, which might have accel-
erated yeast evolvability.
It was also proved that the ability of a mutant yeast strain
(rpb6Q100R) impaired in Rpb4/7 recruitment to module mRNA decay
rates during a stress response, in addition to impaired transcription,
is compromised. As a result, while the wild type features counterac-
tion coupling between production and degradation of mRNA, this
coupling is lost in the mutant [95].
An alternative form of crosstalk between transcription and mRNA
stability is mediated by miRNAs, a class of 21–23 nucleotide-long
noncoding RNAs that target speciﬁc mRNAs by Watson–Crick base-
pairing and promote their degradation or modify their translation
rates. Genome-wide analyses proved most useful in the experimental
identiﬁcation of miRNA targets (reviewed in [96]). Classical transcrip-
tome proﬁling in response to speciﬁc miRNA gain- or loss-of-function
helps deﬁne the set of mRNA targets that can be co-regulated by miR-
NAs with homologous seed regions. Immunoprecipitation of the
Argonauta protein, which speciﬁcally binds miRNAs, in combination
to massive RNA sequencing, allows the deﬁnition of direct targets of
miRNA. The resulting databases of miRNA target genes were utilized
to include miRNAs in the deﬁnition of gene-expression networks. A
good example is the transcriptional response of breast cancer cells
to estrogen signaling [67]. Hah et al. [67] found a statistically signiﬁ-
cant overlapping between estradiol-regulated mRNAs and mRNAs,
which are targets of estradiol-regulated miRNAs. Yet they found no
evidence of a concerted transcriptional regulation of the miRNAs' pre-
cursor genes with the direction (either up or down) of their potential
targets mRNAs' regulation by either GRO-seq or mRNA proﬁling. Evi-
dence for both coordinated and compensatory regulations was found,
indicating the additional level of complexity introduced by miRNA
into gene expression regulation [67].
5.2. Models for trans factor recognition of mRNA targets
How do mRNA-stability regulatory proteins recognize their mRNA
targets? There are, in principle, two places where a given factor can
bind to an mRNA: in the nucleus (Fig. 3, blue ovals) and in the cyto-
plasm (Fig. 3, yellow ovals). In the nucleus, a protein can be loadedRNA binding
Motif-
specific 
General 
RNA feature
Puf 
miRNA
Ssd1
Xrn1
Ccr4-Not
Cth2
PABP
Rpb4/7
EJC
B)
l II (green oval)may have associated factors (blue ovals) that travel with it (e.g., bound to
nce (green box), normally placed at the 3′-UTR, or to any part of the mRNA molecules.
mRNA charged with factors is exported to the cytoplasm, where they can inﬂuence its
bindmRNAs. They can also be sequence-speciﬁc, likemiRNA, or not. If factors are bound
ognize target sequences during transcription, or only in the cytoplasm, establish an as-
m the mRNA. This can be used as a quantitative signal for the titration of the cytoplasmic
or: nuclear or cytoplasmic, which bind speciﬁc or general features on mRNAs.
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any sequence motif (nucleus left arrow). This seems to be the mech-
anism of the Rpb4/7 subunits, which can bind only mRNAs in the RNA
pol II context [87]. Thus, some general factors which bind many
mRNAs may discriminate them to bind on the basis that these
mRNAs are current targets of the transcriptional machinery they
form part of. More gene-speciﬁc factors can be indirectly loaded via
their contact with the general ones (Fig. 3, brown ovals) or can bind
speciﬁc sequences (Fig. 3, nucleus right arrow). All these factors are
exported to the cytoplasm as ribonucleoproteins and can be later re-
leased from their targets. Sequence nonspeciﬁc binding avoids any
possible re-binding in the cytoplasm. Those factors can only be
imported back to the nucleus or be degraded. A similar mechanism
was described for other factors, such as the exon junction complex
(EJC), which binds exon junctions only after intron splicing which,
once released by the ﬁrst translation round, cannot return to its target
[97]. Cytoplasmatic RNA-binding factors (yellow ovals) can be
sequence-speciﬁc or not. The sequence motif for both nuclear and
cytoplasmatic factors can be more or less speciﬁc, but should evolve
together with the factor (protein or RNA) that binds it. By using this
system, an RBP or an miRNA can bind a target in the nucleus or the
cytoplasm at any time following an equilibrium reaction, which can
be controlled by other factors or metabolites. To date, many of the
RBPs described for post-transcriptional regulons follow this scheme.
For instance, the Puf factors described in Drosophila and yeast, and
other related factors in human cells, bind speciﬁc 3′-UTR sequences
and promote mRNA degradation [82,83,98]. In contrast, Ssp1 seems
to bind 5′-UTR sequences [91]. In mammals, many miRNAs are able
to destabilize their target mRNAs, and do so similarly to RBPs [99].
Other cytoplasmatic factors are not sequence-speciﬁc, although they
can bind special mRNA structures such as the cap [101] or the
poly(A) tail. Nonspeciﬁc recognition has the advantage of: broad
speciﬁcity and can be used for general mRNA homeostasis. Cytoplas-
matic factors can titrate the total level of cytoplasmic mRNAs and can
be travelers in the opposite sense, from the cytoplasm to the nucleus,
by carrying this information to the transcription machinery [71].
It is possible that some post-transcriptional regulons can be
based on sequence-speciﬁc RBPs, which bind their speciﬁc target
sequences during their transcription of them. One such example
is the Cth2 protein which binds its mRNA targets in the nucleus,
probably co-transcriptionally, to then promote their degradation
during iron deﬁciency [100]. In this case, RBP's speciﬁcity for a
group of functionally related genes is based on both its target
sequence and the transcriptional machinery reading it, including
the transcription factors that control initiation and/or elongation.
In this way, transcriptional and post-transcriptional regulons
would be interconnected.
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